Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Physiological roles of Ca2+ signals
- Receptor-mediated control of Ca2+ signals
- STIM1 and STIM2 are components of SOCs
- Orai 1 as component of store operated Ca2+ entry
- STIM-Orai coupling details
- Transcriptional mechanisms regulating Ca2+
- The EGR Family of transcription factors
- Wilms tumor suppressor 1 (WT1)
- STIM1 expression is dysregulated in Wilms' tumor
- STIM1 expression is dependent on WT1 and EGR1
- Dysregulation of STIM1 expression in EGR1 KO
- ChIP Analysis of the STIM1 promoter
- Control of STIM1 expression by WT1 and EGR1
- Dynamic EGR1-mediated control of STIM1
- Receptor control of EGR1, STIM1/2, PMCA
- Altered STIM, PMCA expression alters Ca2+
- Inhibition of Ca2+ clearance due to PMCA activity
- STIM1-PMCA role in inhibition of Ca2+ clearance
- Orai1 activation/PMCA inhibition - STIM1 functions
- Polarization of T cells during synapse formation
- STIM1 and PMCA co-localize at the site of PHA
- Identification of the critical STIM1 domain
- STIM1 KD eliminates inhibition of Ca2+ clearance
- Local control of cytosolic Ca2+ content (1)
- Global control of Ca2+ clearance after STIM1 KD
- Local control of cytosolic Ca2+ content (2)
- Remodeling of Ca2+ homeostasis at synapse
- Acknowledgements
Topics Covered
- Basic concepts and physiological implications
- Transcriptional mechanisms in control of STIM1 expression
- Dynamic receptor-mediated STIM1 upregulation
- Delayed Ca2+ clearance during T cell activation
- Role of STIM1 in this process
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Soboloff, J. (2020, August 12). Mechanisms regulating STIM expression and function in Ca2+ signaling [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/PAIP1774.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Jonathan Soboloff has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Mechanisms regulating STIM expression and function in Ca2+ signaling
A selection of talks on Oncology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello my name is Jonathan Soboloff and
today I'm going to talk a little bit
about some recent work performed in
my lab, investigating mechanisms
regulating STIM expression and
function in calcium signaling.
0:14
Before getting too far
into my current research,
I'd like to talk a little about the
physiological roles of calcium signals.
Calcium signals control a wide variety
of distinct physiological events.
Whereas calcium signals themselves
typically occur quite rapidly in a time
frame of seconds to minutes,
the physiological consequences of these
signals can last over
a much longer time period.
Some of the immediate effects of calcium
signals can be detected immediately
over a time frame,
similar to the calcium signal itself.
For example, muscle contraction, changes
in the metabolic state of certain enzymes,
or membrane fusion, such as for
example in secretion.
Other calcium signals occur
over a much longer time frame,
really long after the calcium
signal has already ended,
such as changes in gene expression,
changes in cell proliferation, or
changes in apoptosis (otherwise
known as cell death).
The major goal of my lab is to understand
this link between short-term changes
in calcium signals and these
longer-term changes in cell function.
1:20
Now I'd like to talk a little about
receptor-mediated control of calcium
signals.
At rest, the concentration of
calcium in the cytosol is many-fold
lower than outside of the cell or
in the lumen of the.
This difference is maintained by
the combined action of the plasma
membrane calcium ATPase (PMCA) and
the sarco/endoplasmic reticulum
calcium ATPase (SERCA).
When a ligand binds to a PLC
(phospholipase C-coupled receptor),
it initiates a series of events leading
to elevation of cytosol calcium
concentration.
The first step in this process is
breakdown of phosphatidyl inositol (PIP2)
into two bio-active metabolites,
diacylglycerol (DAG) and IP3.
DAG has a number of different targets,
one of which is receptor-operated calcium
channels (ROCs), which upon binding
of diacylglycerol permit the entry of
calcium into the cytosol from
the extracellular space.
IP3 binds to its receptor on the Membrane,
causing the movement of calcium
out of the Lumen and into the cytoplasm,
and this movement of calcium out
of the Lumen tends to cause
a depletion of Calcium concentration.
This Calcium depletion leads to the
activation of a separate class of calcium
channels, termed store-operated
calcium channels (SOCs).
Because both SOCs and ROCs are activated
downstream of receptors at least
physiologically, there's been a great
deal of confusion over the years over
whether a channel is receptor-operated or
store-operated.
Much of this confusion was
addressed in 2005 and 2006,
with the identification of
the molecular mediators of SOC and
it's these proteins that have been
the focus of my research since that time.